Mya Mu Aye

Mya Mu Aye


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2019 in Molecules
Verified
Journal Article
Open access
PDF file
MAMya Mu Aye
Mya Mu Aye
HAHnin Thanda Aung
Hnin Thanda Aung
MSMyint Myint Sein
Myint Myint Sein
CAChabaco Armijos
Chabaco Armijos
Medicinal plants are a reservoir of biologically active compounds with therapeutic properties that over time have been reported and used by diverse groups of people for treatment of various diseases. This review covers 15 selected medicinal plants distributed in Myanmar, including Dalbergia cultrata, Eriosema chinense, Erythrina suberosa, Millettia pendula, Sesbania grandiflora, Tadehagi triquetrum, Andrographis echioides, Barleria cristata, Justicia gendarussa, Premna integrifolia, Vitex trifolia, Acacia pennata, Cassia auriculata, Croton oblongifolius and Glycomis pentaphylla. Investigation of the phytochemical constituents, biological and pharmacological activities of the selected medicinal plants is reported. This study aims at providing a collection of publications on the species of selected medicinal plants in Myanmar along with a critical review of the literature data. As a country, Myanmar appears to be a source of traditional drugs that have not yet been scientifically investigated. This review will be support for further investigations on the pharmacological activity of medicinal plant species in Myanmar.

1 March 2016 in Natural Product Communications
Verified
Journal Article
Open access
PDF file
HAHnin Thanda Aung
Hnin Thanda Aung
MSMyint Myint Sein
Myint Myint Sein
MAMya Mu Aye
Mya Mu Aye
ZTZaw Min Thu
Zaw Min Thu
Medicinal plants are a vital source of medication in developing countries. In Kachin State, Northern Myanmar, the people have a long history of the use of traditional plants for medicinal purposes. This article deals with the 25 most used medicinal plants in Kachin State. They are: Drynaria fortunei, Tetrastigma serrulatum, Bauhinia championii, Goniothalamus cheliensis, Juglans regia, Houttuynia cordata, Osmanthus fragrans, Pothos chinensis, Tabemaemontana coronaria, Eryngium foetidum, Chloranthus spicatus, Peperomia pellucida, Zanthoxylum armatum, Polygonum fagopyrum, Cymbidium floribundum, Amomum kravanh, Coscinium fenestratum, Solanum nigrum, Gnetum parvifolium, Desmodium triquetum, Begonia augustinec, Mappianthus iodoides, Erycibe obtusifolia, Schefflera venulosa, Holarrhena antidysenterica. The different traditional applications, the known chemical constituents and medicinal properties are reported for each plant. The efficacy of several of these plants has been supported by some scientific evidence, while other plants have to be submitted to further investigations to prove the beneficial medicinal properties attributed to them.

18 March 2020 in Records of Natural Products
Verified
Journal Article
Closed access
HAHnin Thanda Aung
Hnin Thanda Aung
MAMya Mu Aye
Mya Mu Aye
ZTZaw Min Thu
Zaw Min Thu
YKYumiko Komori
Yumiko Komori
MSMyint Myint Sein
Myint Myint Sein
YTYoshiaki Takaya
Yoshiaki Takaya
Analysis of the MeOH extract of rhizomes of Sansevieria cylindrica using repeated silica gel and reversed-phase chromatographic separations led to the isolation of ten phenolic compounds (1-10) belonging to five different classes. Their structures, including the absolute configuration, were identified by NMR and CD spectra analysis. The antiradical activity of isolated compounds was tested using the DPPH scavenging method. The cytotoxic effects were assayed against a Hela cell line. Compounds 2-10 have been isolated from a Sansevieria species from the first time and compounds 4-10 have been isolated from species of the Asparagaceae family for the first time. The structure of a homoisoflavanone isolated from S. roxburghiana has been corrected.

18 April 2021
Verified
Conference Paper
Open access
PDF file
VBVictoria Beraud
Victoria Beraud
ARAhsen Razzaq
Ahsen Razzaq
MAMya Mu Aye
Mya Mu Aye
JSJodie Savage
Jodie Savage
Background In many countries, children under the age of 16 are seen in both primary and secondary care. In the UK and Ireland however, there’s a network of tertiary specialist centres known as Principal Treatment Centres (PTCs). These are very important as they coordinate and designate the most qualified hospital for children and young people (CYP) with cancer, making sure they are given the best treatment possible. Each PTCs share care with local hospitals through Paediatric Oncology Shared Care Units (POSCU), enabling children to be supported and treated closer to home. Furthermore, every CYP with cancer are offered a Key Worker, their main point of contact who provides support throughout their convalescence and ensures the appropriate co-ordination of care. An oncology lead specialist nurse and her team provide different types of services, such as central lines care at home, taking blood, educating schools and reducing any barriers or concerns, to social work like providing support for daily living, giving advice on housing or financial issues. Objectives Our aim is to demonstrate the beneficial impact of these services on patients and their families by analysing the satisfaction and support provided to them. Methods Two surveys on patient and parent’s satisfaction in paediatric oncology services at local POSCU were conducted, with questionnaires given to all families on active treatment during these periods. The first survey was done in 2016 with 55% responses and results were compared with two national and regional existing surveys. The second survey was done in 2020 with 54% responses. Results The importance of POSCU is evidenced in both surveys. In the 2020 survey, all participants felt a sense of trust/confidence with the paediatric community nurses/consultants; and in the 2016 survey, all participants believed the care of the CCN was very satisfactory. Both survey results show the significance of a shared care plan and the effect it has on patient satisfaction. A negative feature of any shared care plan is miscommunication between the PTC and local hospital; however, the survey responses in 2020 showed that no one felt the communication between the local and PTC was below satisfactory (with 71% definitely satisfied). This was also supported in the 2016 survey where 91% felt communication between the POSCU and PTC was well/very well. In the 2020 survey a patient explained that ‘communications between local & PTC […] have been excellent’, further emphasising good communication between the two centres. Additionally, POSCU is valued by patients’ families, being described in the 2020 survey as ‘the best treatment from […] extraordinary Paediatric Consultant, and from all the Community Nurses’. Conclusions To conclude, both these surveys showed the beneficial impact of POSCU in the care of CYP with cancer and their families but also the satisfaction of the support brought by these services. This study shows the importance of having these services in place to help reduce these miscommunications and support locally. Based on these results, POSCU services should be further analysed and considered in other areas and countries, promising a great beneficial impact on children and their families.